BK vs RPID · P/E 17, rev $20.08B vs rev $28.1M
The Bank of New York Mellon Corporation (BK) versus Rapid Micro Biosystems Inc (RPID) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Rapid Micro Biosystems Inc (RPID) is a medical devices company listed on NASDAQ.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Latest reported RPID revenue for 2024-12-31 was $28.1M. Net income was -$46.9M. Revenue was up 24.6% from 2023-12-31 to 2024-12-31. RPID currently screens at market cap $85.7M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. RPID currently screens at market cap $85.7M.
Not investment advice. Open the BK and RPID stock pages for the full models.
Not investment advice.